Seaport Therapeutics Files S-1/A Amendment
Ticker: SPTX · Form: S-1/A · Filed: Apr 27, 2026 · CIK: 0002042347
| Field | Detail |
|---|---|
| Company | Seaport Therapeutics, Inc. (SPTX) |
| Form Type | S-1/A |
| Filed Date | Apr 27, 2026 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, s-1/a, securities-registration
TL;DR
Seaport Therapeutics filed an S-1/A on 4/27/26. Details on securities registration.
AI Summary
Seaport Therapeutics, Inc. filed an S-1/A amendment on April 27, 2026, to register securities. The filing includes various exhibits detailing the company's structure, agreements, and financial information, but does not specify dollar amounts or dates for the securities offering itself.
Why It Matters
This S-1/A filing indicates Seaport Therapeutics is moving forward with a securities registration, a crucial step for public offerings or significant capital raises.
Risk Assessment
Risk Level: medium — S-1/A filings are typically associated with initial public offerings or significant capital raises, which inherently carry market and execution risks.
Key Numbers
- 2026-04-27 — Filing Date (Date the S-1/A amendment was accepted by the SEC.)
Key Players & Entities
- Seaport Therapeutics, Inc. (company) — Filer of the S-1/A amendment
- 0002042347 (company) — CIK number for Seaport Therapeutics, Inc.
- 0001193125-26-178716 (filing_id) — SEC Accession Number for the S-1/A filing
- 2026-04-27 (date) — Filing date of the S-1/A amendment
FAQ
What is the purpose of this S-1/A filing?
The S-1/A filing is an amendment to the registration statement for securities under the Securities Act of 1933.
When was this amendment filed?
The amendment was filed and accepted by the SEC on April 27, 2026.
What type of company is Seaport Therapeutics, Inc.?
Seaport Therapeutics, Inc. is the filer of this S-1/A amendment, indicating it is involved in the registration of securities.
What is the SEC Accession Number for this filing?
The SEC Accession Number for this filing is 0001193125-26-178716.
Does the filing specify the number of shares or the price range for the securities being registered?
This particular S-1/A filing document, as presented, does not explicitly state the number of shares or the price range for the securities being registered; it primarily lists exhibits and filing details.
Filing Details
This Form S-1/A (Form S-1/A) was filed with the SEC on April 27, 2026 regarding Seaport Therapeutics, Inc. (SPTX).